Glucotrack (GCTK) Total Debt Growth (3y) (2014)
Powered by 
Analysis
Glucotrack (GCTK) Total Debt Growth (3y) (2014) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 181.19 Bn | 175.58 Bn | 7.27 Bn | 24.63% |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.13 Bn | 108.31 Bn | 6.34 Bn | 4.06% |
| 4 | Stryker | 104.67 Bn | 101.20 Bn | 4.50 Bn | 4.89% |
| 5 | Boston Scientific | 64.48 Bn | 63.94 Bn | 3.85 Bn | 11.72% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 0.11% |
| 7 | Alcon | 33.06 Bn | 31.61 Bn | 1.68 Bn | 252.76% |
| 8 | Dexcom | 32.37 Bn | 30.43 Bn | 830.00 Mn | - |
| 9 | Steris | 20.76 Bn | 20.28 Bn | 684.20 Mn | -10.56% |
| 10 | Glucotrack | 1.06 Mn | -68,752.73 | - | - |